Annamalai University Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2002
NCT00255385
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (4)

bifidobacterium longum (1 trial)

chlorhexidine (hibitane) (1 trial)

iron (2 trials)

zn2+ (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diarrhea (Phase 3)

Iron Overload (Phase 3)

Pneumonia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4